Equities

China NT Pharma Group Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

China NT Pharma Group Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)0.79
  • Today's Change0.00 / 0.00%
  • Shares traded130.10k
  • 1 Year change+225.10%
  • Beta0.2675
Data delayed at least 15 minutes, as of Feb 05 2026 06:15 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

China NT Pharma Group Co Ltd is an investment holding company principally engaged in the digital services businesses. The Company operates its business through two segments. The Digital Services segment is mainly engaged in the provision of marketing and promotion in relation to bone health knowledge. The Sales Agency Service segment is mainly engaged in acting as agent for clients to sell medical and health-related products to external customers.

  • Revenue in HKD (TTM)21.01m
  • Net income in HKD-79.88m
  • Incorporated2010
  • Employees21.00
  • Location
    China NT Pharma Group Co LtdNo. 1 Hualing StreetSuzhou Industrial ParkSUZHOU 200020Hong KongHKG
  • Phone+852 28081606
  • Fax+852 25089459
  • Websitehttp://www.ntpharma.com
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
1011:HKG since
announced
Transaction
value
Zhong He Qun Lian LtdAnnounced28 Apr 202528 Apr 2025Announced97.50%4.44m
Yue Hua LtdAnnounced28 Apr 202528 Apr 2025Announced97.50%4.15m
Junbinxiongdi LtdAnnounced28 Apr 202528 Apr 2025Announced97.50%5.59m
Data delayed at least 15 minutes, as of Feb 05 2026 06:15 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shenzhen Neptunus Intrlng Bi tchnq CoLtd1.12bn6.95m271.84m1.47k39.090.34136.510.2430.00410.00410.66660.47470.7833.685.65753,224.30-0.42952.52-0.63293.7629.1243.41-0.54863.331.482.030.1157139.17-2.18-0.73563.68-15.97-7.87--
Regent Pacific Group Ltd7.15m-31.85m280.14m17.00------39.18-0.1388-0.13880.0312-0.11161.20--6.96420,577.10-535.26-47.86---61.88-----445.46-1,658.64---11.90----153.632.1782.11---5.59--
Hin Sang Group (Interntnl) Hldng Co Ltd95.53m-40.10m289.33m185.00--2.04--3.03-0.0367-0.03670.08750.12990.16792.4212.62459,278.80-7.03-5.77-13.64-8.4167.2858.19-41.89-36.550.0735-0.33330.7032---0.7882-12.21-34.48---50.36--
Wai Yuen Tong Medicine Holdings Ltd721.27m-13.83m416.29m726.00--0.35195.630.5772-0.0123-0.01230.64111.050.41651.419.68950,292.50-0.7998-1.81-1.06-3.1049.8744.67-1.92-11.190.7806--0.2033---4.923.73126.62-56.1631.89--
China NT Pharma Group Co Ltd21.01m-79.88m532.65m21.00------25.35-0.2317-0.23170.0485-0.46250.0546--3.09955,199.40-20.76-10.31----51.27---380.13-97.110.0447-0.39737.95--415.34-24.38-59.32---71.03--
Fusen Pharmaceutical Co Ltd271.43m-197.08m547.08m1.05k--1.40--2.02-0.2666-0.26660.36710.5280.18751.114.05239,990.20-13.62-2.83-32.04-5.4041.3951.61-72.61-8.000.4241-0.43440.5137---42.36-4.36-420.39---17.55--
Modern Chinese Medicine Group Co Ltd227.74m21.37m554.40m190.0021.610.844916.012.430.03560.03560.37960.91140.3925.897.491,198,625.003.6814.833.9317.5624.5738.449.3817.927.8021.300.00032.85-37.78-0.4333-80.18-26.87112.81--
Zhongzhi Pharmaceutical Holdings Ltd2.26bn23.15m621.79m2.49k26.240.50854.340.27510.02740.02742.681.421.052.666.45877,100.401.096.771.6810.4757.1959.641.035.911.0651.800.113438.978.0510.54-41.51-3.6513.6210.79
Uni-Bio Science Group Ltd589.59m91.35m662.81m504.007.281.735.791.120.01520.01520.09760.06411.133.629.181,210,657.0017.516.2122.178.5682.1980.7215.494.963.2259.390.221,633.5814.0821.4316.79102.0432.65--
Pak Fah Yeow International Ltd199.03m70.97m747.94m100.0010.541.069.643.760.22770.22770.63862.260.22271.8424.741,877,594.007.945.038.685.2487.4482.2335.6623.926.217.720.006894.02-8.649.89-25.1416.8816.37-8.84
Data as of Feb 05 2026. Currency figures normalised to China NT Pharma Group Co Ltd's reporting currency: Hong Kong Dollar HKD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.